PathoSearch is now in early access.

Join the waitlist

AI-powered tissue analysis, validated by pathologists

H&E
cell classification

Who We Serve

Life Sciences

Leading technologies for research and biomarker development, from hypothesis generation to clinical trial biomarkers.

Foundation model licensing
HETA (H&E Tissue Application)
Pre-computed validation datasets
Biomarker and target solutions

Clinical

Support for the pathology lab, from resolving difficult cases to automated measurement, without leaving your workflow.

PathoSearch
HETA Clinical products

Academics

Select research offerings, derived from our products, available free of charge to accelerate high-impact academic projects

OpenTME
Research Access Program
Foundation models for research
Who We Are

Interdisciplinary team with deep functional competency

Aignostics is a spin-off from Charité Berlin, one of Europe’slargest and most esteemed university hospitals. Today,our team has grown to include a diverse array of cross-functional experts working from our offices in Berlin and New York.

/CERTIFICATION

ISO 13485 and 27001 certified

GCP-ready clinical trial platform

/Recent Awards

Featured Publications

arXiv, August 2026 - Paper

LUCAID: Agentic Multimodal AI for Lung Cancer Precision Pathology

Marie-Lisa Eich, Kai Standvoss, Timo Milbich, et al
arXiv, January 2026 - Paper

Mind the Gap: Continuous Magnification Sampling for Pathology Foundation Models

Alexander Möllers, Julius Hense, Florian Schulz, et al
arXiv, June 2026 - Paper

Atlas H&E-TME: Scalable AI-Based Tissue Profiling at Expert Pathologist-Level Accuracy

Kai Standvoss, Miriam Hägele, Rosemarie Krupar, et al

In the news

12.9.2026

Aignostics Launches PathoSearch, a Visual Search Engine for Pathology Cases

23.6.2026

Atlas H&E-TME Exceeds the Performance of Expert Pathologists

9.6.2026

Aignostics Partners with the Pancreatic Cancer Action Network to Advance Pancreatic Cancer Research

Stay in the loop

Fill out the form to subscribe to our company newsletter, a periodic look at what we're building, who we're working with, and how teams are putting AI-powered pathology to work.

Fill out the form

AI-powered tissue analysis, validated by pathologists.